Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Brain Metastases

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · 520-694-8900
    Contact: Principal Investigator (Baldassarre Stea)
  • University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Baldassarre Stea)
  • City of Hope Corona, Corona, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 626-256-4673
    Contact: Principal Investigator (Sean Szeja)
  • City of Hope Comprehensive Cancer Center, Duarte, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Sean Szeja)
  • City of Hope at Irvine Lennar, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-467-3411
    Contact: Principal Investigator (Sean Szeja)
  • UC San Diego Moores Cancer Center, La Jolla, California, United States

  • City of Hope Antelope Valley, Lancaster, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Sean Szeja)
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

  • Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States

  • Rohnert Park Cancer Center, Rohnert Park, California, United States

  • The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States

  • South Sacramento Cancer Center, Sacramento, California, United States

  • Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States

  • City of Hope South Pasadena, South Pasadena, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Sean Szeja)
  • Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States

  • City of Hope South Bay, Torrance, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-467-3411
    Contact: Principal Investigator (Sean Szeja)
  • City of Hope Upland, Upland, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Sean Szeja)
  • Boca Raton Regional Hospital, Boca Raton, Florida, United States

  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Benjamin J. Rich)
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Benjamin J. Rich)
  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States

  • Mayo Clinic in Florida, Jacksonville, Florida, United States

  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Benjamin J. Rich)
  • Memorial Hospital West, Pembroke Pines, Florida, United States

  • UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Benjamin J. Rich)
  • Moffitt Cancer Center, Tampa, Florida, United States

  • Piedmont Hospital, Atlanta, Georgia, United States

  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

  • Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States

  • Northwestern University, Chicago, Illinois, United States

  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Loyola University Medical Center, Maywood, Illinois, United States

  • HSHS Saint Elizabeth's Hospital, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Methodist Medical Center of Illinois, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • OSF Saint Francis Medical Center, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

  • Community Cancer Center North, Indianapolis, Indiana, United States

  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Luminis Health Anne Arundel Medical Center, Annapolis, Maryland, United States

  • Walter Reed National Military Medical Center, Bethesda, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 301-319-2100
    Contact: Principal Investigator (Corbin A. Helis)
  • Tufts Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · ContactUsCancerCenter@TuftsMedicalCenter.org · 617-636-5000
    Contact: Principal Investigator (John E. Mignano)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CancerAnswerLine@med.umich.edu · 800-865-1125
    Contact: Principal Investigator (Michelle M. Kim)
  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

  • Regions Hospital, Saint Paul, Minnesota, United States

  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · sfmc@sfmc.net · 573-334-2230
    Contact: Principal Investigator (Bryan A. Faller)
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Jiayi Huang)
  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Jiayi Huang)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Jiayi Huang)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Jiayi Huang)
  • Missouri Baptist Medical Center, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Billings Clinic Cancer Center, Billings, Montana, United States

  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, United States

  • AtlantiCare Surgery Center, Egg Harbor, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 609-748-7200
    Contact: Principal Investigator (James C. Wurzer)
  • State University of New York Upstate Medical University, Syracuse, New York, United States

    Contact: Study coordinator (Site Public Contact) · 315-464-5476
    Contact: Principal Investigator (Michael D. Mix)
  • SUNY Upstate Medical Center-Community Campus, Syracuse, New York, United States

  • Mission Hospital, Asheville, North Carolina, United States

  • Cone Health Cancer Center, Greensboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · stacey.phelps@conehealth.com · 336-832-0836
    Contact: Principal Investigator (Sarah E. Squire)
  • East Carolina University, Greenville, North Carolina, United States

  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 336-713-6771
    Contact: Principal Investigator (Michael D. Chan)
  • Sanford Bismarck Medical Center, Bismarck, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

  • Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · cancer@lhs.org · 800-220-4937
    Contact: Principal Investigator (Andrew Y. Kee)
  • Geisinger Medical Center, Danville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Heath B. Mackley)
  • Fox Chase Cancer Center Buckingham, Furlong, Pennsylvania, United States

  • Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Heath B. Mackley)
  • Self Regional Healthcare, Greenwood, South Carolina, United States

  • Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

  • Dartmouth Cancer Center - North, Saint Johnsbury, Vermont, United States

  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (Michael W. Straza)
  • Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta, Canada

    Contact: Study coordinator (Site Public Contact) · ctsucontact@westat.com · 888-823-5923
    Contact: Principal Investigator (Muhammad S. Faruqi)
  • Cross Cancer Institute, Edmonton, Alberta, Canada

    Contact: Study coordinator (Site Public Contact) · 780-432-8500
    Contact: Principal Investigator (Samir I. Patel)
  • BCCA-Vancouver Cancer Centre, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Site Public Contact) · 888-939-3333
    Contact: Principal Investigator (Alan M. Nichol)
  • QEII Health Sciences Centre/Nova Scotia Health Authority, Halifax, Nova Scotia, Canada

    Contact: Study coordinator (Site Public Contact) · 902-473-6000
    Contact: Principal Investigator (Michael N. Ha)
  • Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada

  • London Regional Cancer Program, London, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · 519-685-8600
    Contact: Principal Investigator (Melody Qu)
  • University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · clinical.trials@uhn.on.ca · 416-946-4501
    Contact: Principal Investigator (David B. Shultz)
  • CSSS Champlain-Charles Le Moyne, Greenfield Park, Quebec, Canada

  • CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada

    Contact: Study coordinator (Site Public Contact) · info.cr.chum@ssss.gouv.qc.ca · 514-890-8000
    Contact: Principal Investigator (David Roberge)
  • The Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec, Canada

  • Jewish General Hospital, Montreal, Quebec, Canada

    Contact: Study coordinator (Site Public Contact) · 514-340-8222
    Contact: Principal Investigator (Thierry M. Muanza)
  • CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ), Québec, Quebec, Canada

    Contact: Study coordinator (Site Public Contact) · rechclinique@crchuq.ulaval.ca
    Contact: Principal Investigator (Isabelle Thibault)
  • Centre Hospitalier Universitaire de Sherbrooke-Fleurimont, Sherbrooke, Quebec, Canada

מובילי המחקר
  • David Roberge

    Study Chair

    CHUM-Centre Hospitalier de l'Universite de Montreal

  • Michael Chan

    Study Chair

    Wake Forest School of Medicine, Winston-Salem, NC

  • Vina Gondi

    Study Chair

    Northwestern Medicine Cancer Center, Warrenville IL